Product Code: MCP-7970
This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 21 companies including many key and niche players such as -
Abbott Laboratories
Aleva Neurotherapeutics SA
Boston Scientific Corp.
Deep Brain Innovations, LLC
Medtronic Plc
Beijing Pins Medical Co., Ltd.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
- A Prelude
- Introduction to Deep Brain Stimulation Devices
- Deep Brain Stimulation - Then and Now
- Global Market Overview
- Competitive Landscape
- Table 1: Global DBS Market by Leading Player (2016 & 2017E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott (includes corresponding Graph/Chart)
- Table 2: The US DBS Market by Leading Player (2016 & 2017E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott (includes corresponding Graph/Chart)
- Table 3: Rest of World (Exc. US) DBS Market by Leading Player (2016 & 2017E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott (includes corresponding Graph/Chart)
- Select Available Deep Brain Stimulation Devices Available in the Market
- Recent Advancements and the Way Ahead
2. MARKET DYNAMICS
- DBS Market Driven by the Minimally Invasive Treatment Conferred
- Hybrid DBS Devices Witness Increased Demand
- Aging Population and Rising Disease Prevalence: The Cornerstone for DBS
- Table 4: Global Population Statistics for the 65+ Age Group (2016) (includes corresponding Graph/Chart)
- Table 5: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart)
- Rising Healthcare Expenditure Induces Momentum in the Market
- Table 6: Healthcare Spending as % of GDP by Region (2016) (includes corresponding Graph/Chart)
- Novel Applications Bode Tremendous Prospects
- Technical Advancements Aid in Progress of DBS
- Still Questions Arise on the Current Pace of Innovation
- Closed-Loop Functionality Gaining Favor over Open-Loop in Neurostimulation
- Investigational DBS Device Inches towards Closed-Loop Functionality
- Promising Targets for PIGD
- Steering Brain Stimulation - An Emerging Concept in DBS
- Novel Leads Target Selective and Fractional Stimulation
- Researchers Devise Temporal Interference Method for Non-Invasive Deep Brain Stimulation
- Researchers Develop New Pulse Pattern to Improve DBS for Parkinson's
- Researchers Eye Deep Brain Stimulation to Treat Depression
- Role of DBS in Managing Movement Disorders among Children
- Novel Electrode Configurations Aid in Localization and Side Effect Reduction
- Nanotechnology - The Future of DBS Electrodes
- On-Demand Stimulators Promise to Contribute to Superior Therapeutic Outcomes
- Sophisticated Neurostimulators
- Advances in Programming Promise Ease of Treatment
- Visual Depiction of Electrical Field Comes to the Aid of Programming
- Device Programmability Gains Precedence in Device Choice
- Brain Imaging - Gaining Prominence in DBS
- Novel Imaging Techniques Come to the Fore
- New DBS Technique Promises Superior Outcomes
- Lack of Large Scale Study Results Subdue Asleep DBS; for Now
- Concerns Remain Afloat - Affecting Adoption
- Hardware-related Infections - A Major Concern
- Battery Life - A Bone of Contention for DBS
3. TARGETED INDICATIONS FOR DBS
- Parkinson's Disease - The Largest Application Market for DBS
- The DBS Procedure for Parkinson's
- Limitations of DBS
- A Note on Incidence and Prevalence of Parkinson's Disease
- Table 7: Parkinson's Prevalence (In Million) by Income Category, Projections for 2005, 2015, and 2030 (includes corresponding Graph/Chart)
- Research Suggests Greater Benefits of DBS in Parkinson's
- Innovations in DBS to Redefine Future of Parkinson's Treatment
- Innovations Upgrading Current Devices
- Novel Stimulation Patterns and Parameters
- Innovation in Enhanced Stimulation
- Researchers Develop New Pulse Pattern to Improve DBS for Parkinson's
- DBS - A Highly Effective Therapy for Essential Tremor
- Incidence and Prevalence of Essential Tremor
- DBS in Dystonia
- Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical Studies and Meta-Analyses
- Dystonia Patient Selection Criteria for DBS
- DBS in OCD
- DBS in Epilepsy Treatment
- Disease Overview
- Table 8: Epilepsy Incidence by Type (2016): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy (includes corresponding Graph/Chart)
- Table 9: Symptomatic Epilepsy Incidence by Type (2016): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy (includes corresponding Graph/Chart)
- DBS in Tourette Syndrome - Research Progress So Far
- Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select Clinical Studies and Meta-Analyses
- Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment
- Multiple Possible Targets Marr Progress of DBS in Depression Treatment
- Overview of Select Studies on DBS in Depression Treatment
- SCC - A Promising Target for Stimulation in Depression
- Eating Disorders - A Note on Potential of DBS
- DBS: A Potential Procedure to Treat Obesity
- Anorexia Treatment - Where Does DBS Stand?
- DBS in Dementia Treatment - Animal Studies Bode Well for Efficacy in Humans
- Prospects of DBS in Chronic Pain Management
4. PRODUCT OVERVIEW
- Deep Brain Stimulation - An Overview
- A Brief Note on Birth and Evolution of DBS
- Devices in Deep Brain Stimulation
- Components of DBS System
- Implantable Pulse Generator (IPG)
- The Extension
- Leads/Electrodes
- Other Products used in DBS Procedures
- Programmers
- Accessories
- DBS Procedure - A Brief Overview
- DBS Placement and Calibration
- Common Lead Targets for Select Neurological and Psychiatric Conditions in DBS
- A Peek into Indications of DBS and Other Uses
- DBS Complications
- A Gist of Common Complications Associated with DBS
5. RECENT INDUSTRY ACTIVITY
- Boston Scientific Earns CE Mark for Vercise Gevia DBS System
- Medtronic SureTune(TM)3 Receives CE Mark for DBS Therapy
- Medtronic SureTune(TM)3 Earns Health Canada Licence for DBS
- Aleva Neurotherapeutics Plans to Obtain CE Mark for directSTIM(tm) Directional DBS System
- St. Jude Medical Announces US FDA Approval & First Implant of DBS and Directional Lead
- Medtronic's StealthStation Cranial Software gets FDA Clearance
- Medtronic SureTune2(TM) Secures CE Mark for DBS Therapy
- St Jude Medical Introduces the Infinity DBS System and Directional Lead
- Medtronic DBS Therapy Receives FDA Approval
- Abbott Takes Over St. Jude Medical
- Aleva Neurotherapeutics Inks Strategic Partnership with Greatbatch
- Medtronic Deep Brain Stimulation Receives FDA Approval
- FDA Approves Activa Portfolio of DBS Neurostimulators for Full-Body MRI
- Boston Scientific Receives CE Mark for Vercise DBS System for Treating Tremor
- St. Jude Medical Secures US FDA Approval for Brio Neurostimulation System
- Medtronic Obtains EU Clearance for Full-Body MR Conditional DBS Systems
6. FOCUS ON SELECT PLAYERS
- Abbott Laboratories (USA)
- Aleva Neurotherapeutics SA (Switzerland)
- Boston Scientific Corp. (USA)
- Deep Brain Innovations, LLC (USA)
- Medtronic Plc. (Ireland)
- Beijing Pins Medical Co., Ltd. (China)
- SceneRay Corporation Limited (China)
7. GLOBAL MARKET PERSPECTIVE
- Table 10: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 11: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 12: World 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
- A. Market Analysis
- United States Leads the Global DBS Market
- Table 13: Prevalence of Major Neurological Disorders in the US (includes corresponding Graph/Chart)
- Medtronic Leads the US Market, Faces Competition from Abbott and Boston
- Table 14: The US DBS Market by Leading Player (2016 & 2017E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott (includes corresponding Graph/Chart)
- Factors Hampering the Uptake of DBS, and Manufacturers' Initiatives
- Use of DBS in Early-Stage PD to Offer Improved Results
- Aging Population: A Key Growth Driver
- Table 15: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
- Table 16: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
- DBS Reimbursement Scenario in the US
- Medicare HCPCS II Device Codes for DBS
- Table 17: CPT(r) Procedure Codes and Facility Payment for DBS for the period-January 1st 2017 to December 31st 2017
- Table 18: CPT(r) Procedure Codes and Hospital Outpatient Payment for the period January 1st 2017 to December 31st 2017
- Table 19: CPT(r) Procedure Codes and Hospital Inpatient Payment for the Period January 1st 2017 to December 31st 2017
- Table 20: CPT(r) Procedure Codes and Ambulatory Surgical Center (ASC) Payment for the period January 1st 2017 to December 31st 2017
- Product Launches
- Strategic Corporate Developments
- Select Key Players
- B. Market Analytics
- Table 21: The US Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 22: The US Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
2. CANADA
- A. Market Analysis
- B. Market Analytics
- Table 23: Canadian Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 24: Canadian Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
3. JAPAN
- A. Market Analysis
- Graying Population Spurs Growth of CNS Therapeutics
- Table 25: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
- DBS Approvals in Japan
- List of Approved and Investigational Indications for Deep Brain Stimulation
- B. Market Analytics
- Table 26: Japanese Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 27: Japanese Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
4. EUROPE
- A. Market Analysis
- Current & Future Analysis
- Table 28: European Country-wise Statistics of 65+ Population as % of Total Population: As on January 1, 2015 (includes corresponding Graph/Chart)
- Product Approvals/Launches
- Select Key Players
- B. Market Analytics
- Table 29: European Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 30: European Historic Review for Deep Brain Stimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 31: European 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
- A. Market Analysis
- Current & Future Analysis
- China and India Offer Significant Growth Opportunities
- Table 32: China and India Lead Global Population (2015): Table Depicting China and India's Huge Population Vis-a-vis Other Countries' Population (in Millions) by Age Group (includes corresponding Graph/Chart)
- Select Key Players
- B. Market Analytics
- Table 33: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 34: Asia-Pacific Historic Review for Deep Brain Stimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 35: Asia-Pacific 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5a. CHINA
- A. Market Analysis
- China - Fastest Growing Market for DBS
- B. Market Analytics
- Table 36: Chinese Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 37: Chinese Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
5b. INDIA
- A. Market Analysis
- Indian DBS Market on the Roll
- Growing Medical Tourism to Support DBS Market in India
- B. Market Analytics
- Table 38: Indian Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 39: Indian Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
- A. Market Analysis
- Current & Future Analysis
- Overview of the Australian DBS Market
- Competitive Landscape
- B. Market Analytics
- Table 40: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 41: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
6. LATIN AMERICA
- Market Analysis
- Table 42: Latin American Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 43: Latin American Historic Review for Deep Brain Stimulation Devices by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 44: Latin American 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
7. REST OF WORLD
- Market Analysis
- Table 45: Rest of World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
- Table 46: Rest of World Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
